Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus

AimsAs metabolic remodeling is a pathological characteristic in type 2 diabetes (T2D), we investigate the roles of newly developed long-acting glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as dulaglutide and liraglutide on metabolic remodeling in patients with recent-onset T2D.MethodsWe...

Full description

Bibliographic Details
Main Authors: Juan Du, Liuqing Xi, Zhongxiao Zhang, Xiaoxu Ge, Wenyi Li, Wenfang Peng, Xiaohong Jiang, Wen Liu, Nan Zhao, Xingyun Wang, Xirong Guo, Shan Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
type 2 diabetes mellitus
metabolic remodeling
dulaglutide and liraglutide
Glycerophospholipids
LC-MS
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1097612/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.1097612/full

Similar Items